跳至主要内容
临床试验/NCT04027166
NCT04027166已完成早期 1 期

Effects of Methadone on Cognitive Function and Pain Threshold

Yale University1 个研究点 分布在 1 个国家目标入组 27 人开始时间: 2019年7月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
已完成
入组人数
27
试验地点
1
主要终点
changes in cognitive functioning using the go no go task

研究概览

简要总结

Male and female participants, over the age of 18, with OUD currently receiving methadone will be enrolled. This within-subject study design will assess pain and cognitive performance in individuals with OUD engaged in MMT. Participants will be asked to complete two separate 4-hour sessions that will be spaced approximately 2-15 days apart. The two sessions will differ based on methadone administration to evaluate study variables in methadone peak (immediately after dose) and trough (20-24 hour after last dose) states. The order of these sessions will be counterbalanced across participants. At the beginning of each session, participants will complete a pain sensitivity task at baseline and post-methadone administration to determine pain threshold and tolerance. Participants will then complete computerized cognitive assessments of working memory, set-shifting, attentional bias, and behavioral inhibition. The cognitive assessments will administered across three time-points (0, 90, and 180 minutes). Pain threshold and tolerance will be measured again after 240 minutes. In addition, opioid craving, withdrawal, pain intensity, and emotional valence will be repeatedly assessed during 240 minute session.

详细描述

After completion of the phone screen, eligible participants will be brought into the laboratory, given a description of the study, and assessed on inclusion and exclusion criteria by research personnel. Details pertaining to the cognitive measures, pain measures, and methadone manipulation will be discussed and informed consent will be obtained along with a signed release to allow study personnel to monitor opioid maintenance. Information on medical, psychiatric and drug use histories will be collected. Individuals with a history of vascular problems or high blood pressure will be evaluated by the research physician. In addition, laboratory tests collecting information on blood alcohol content and urine toxicology will be conducted. Participants will be deemed ineligible to participate if they are not medically cleared by research clinician. Veterans who have a positive BAC will be rescheduled and the methadone maintenance program's clinical protocol will be implemented.

All sessions will be conducted at the West Haven VA Connecticut Healthcare Campus. Participants will be asked to complete two sessions, approximately 2-15 days apart. Order of peak and trough sessions will be counterbalanced between participants. Each session will last approximately four hours. Prior to each testing session, participants will be asked to refrain from caffeine for at least one hour. They will be served a standardized breakfast (i.e., bagel and cream cheese) and offered one smoke break prior to beginning the experimental session. They will be asked to refrain from smoking until the completion of the study protocol. Methadone administration will be coordinated with methadone maintenance treatment staff to relay information about which condition the participant will complete on a given session. At the start of each session, participants will complete computerized cognitive assessments and self-report questionnaires. The computerized cognitive measures will repeated at hours 0, 1.5, and 3. Several state questionnaires will be administered at hours every 30 minutes. Participants will also complete a pain sensitivity measure (i.e., cold pressor task) to assess baseline threshold and tolerance at hour 0 and hour 4.

This study is complete with 27 enrolled and 20 completers.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Males and females, over the age of 18
  • •Diagnosed with opioid dependence and currently enrolled in methadone maintenance treatment
  • •Compliant in opioid maintenance treatment and on a stable dose for two weeks or greater
  • •No current medical problems deemed contraindicated for participation by physician investigator

排除标准

  • •History of psychosis as determined by review of EMR.
  • •Acute suicidal ideation.
  • •History of medical conditions that the physician investigator deems contraindicated for inclusion in the study (e.g., untreated hypertension)

研究组 & 干预措施

administration immediate

Experimental

Methadone will be administered prior to study procedures

干预措施: Methadone (Drug)

administration delayed

Experimental

Methadone will be held for four hours until the end of all study procedures.

干预措施: Methadone (Drug)

结局指标

主要结局

changes in cognitive functioning using the go no go task

时间窗: up to 24 months

during methadone peak and trough states.

次要结局

  • self-reported measures of pain from the cold pressor test(up to 24 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mehmet Sofuoglu

Principal Investigator

Yale University

研究点 (1)

Loading locations...

相似试验